We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEMI
13201
PUT
DELISTED
Chembio diagnostics, Inc.
CEMI
$15K ﹤0.01%
18,300
-1,700
-9% -$1.59K
IMH
13202
DELISTED
Impac Mortgage Holdings Inc.
IMH
$15K ﹤0.01%
+20,528
New +$17.7K
CANF
13203
Can-Fite BioPharma American Depositary Shares
CANF
$7.37M
$14K ﹤0.01%
+57
New +$13.2K
CBUS icon
13204
CALL
Cibus
CBUS
$138M
$14K ﹤0.01%
272
-288
-51% -$21.5K
DUO
13205
Fangdd Network Group
DUO
$24.3M
$14K ﹤0.01%
+10
New +$13.3K
CBIO
13206
Crescent Biopharma
CBIO
$626M
$14K ﹤0.01%
125
-838
-87% -$98.3K
ICUCW
13207
SeaStar Medical Holding Corp Warrant
ICUCW
$14K ﹤0.01%
65,438
JG
13208
CALL
Aurora Mobile
JG
$29.8M
$14K ﹤0.01%
615
-60
-9% -$1.22K
LITB
13209
LightInTheBox
LITB
$55.6M
$14K ﹤0.01%
2,288
-3,957
-63% -$26.5K
RNAC icon
13210
PUT
Cartesian Therapeutics
RNAC
$268M
$14K ﹤0.01%
+373
New +$23.3K
MTVA
13211
CALL
MetaVia Inc
MTVA
$7.69M
$14K ﹤0.01%
6
-34
-85% -$88.6K
BLUA.WS
13212
DELISTED
BlueRiver Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
BLUA.WS
$14K ﹤0.01%
57,644
-67,700
-54% -$30K
AKICW
13213
DELISTED
Sports Ventures Acquisition Corp. Warrant
AKICW
$14K ﹤0.01%
13,971
-1,093,763
-99% -$1.07M
AGTC
13214
CALL
DELISTED
Applied Genetic Technologies Corporation
AGTC
$14K ﹤0.01%
+13,000
New +$23.6K
SWETW
13215
DELISTED
Athlon Acquisition Corp. Warrant
SWETW
$14K ﹤0.01%
56,208
QTNT
13216
PUT
DELISTED
Quotient Limited Ordinary Shares
QTNT
$14K ﹤0.01%
285
-343
-55% -$20.5K
MONDW
13217
DELISTED
Mondee Holdings, Inc. Warrant
MONDW
$14K ﹤0.01%
42,009
+100
+0.2% +$37
CRTD
13218
CALL
DELISTED
Creatd Inc. Common Stock
CRTD
$14K ﹤0.01%
12,400
-39,400
-76% -$61.9K
BDR
13219
DELISTED
Blonder Tongue Laboratories Inc
BDR
$14K ﹤0.01%
+21,950
New +$11.8K
NAVB
13220
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$14K ﹤0.01%
17,562
-41,000
-70% -$37.6K
FENG
13221
Phoenix New Media
FENG
$18M
$13K ﹤0.01%
+3,979
New +$17.2K
LSTA icon
13222
Lisata Therapeutics
LSTA
$9.55M
$13K ﹤0.01%
+1,203
New +$13.8K
SVRN
13223
OceanPal Inc
SVRN
$11.7M
0
RNAC icon
13224
CALL
Cartesian Therapeutics
RNAC
$268M
$13K ﹤0.01%
357
-383
-52% -$24K
SLACW
13225
DELISTED
Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SLACW
$13K ﹤0.01%
32,461
+298
+0.9% +$153

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.